Skip to main content

Pidilite Industries shares climb 2% despite the company reporting a 95% fall in Q1 profit

 The company said Q1 performance was significantly impacted by continued lockdowns due to the coronavirus pandemic.

Shares of Pidilite Industries climbed over 2 percent in morning trade on August 7 even after the company reported a 95 percent year-on-year (YoY) fall in June quarter consolidated net profit at Rs 16 crore.

The company's net sales for the quarter stood at Rs 873 crore, down 56 percent YoY while EBITDA before non-operating income stood at Rs 67 crore, down 85 percent YoY.


The company said Q1 performance was significantly impacted by continued lockdowns due to the coronavirus pandemic.

"On an overall basis, we had a near-complete closure on April 20 with recovery from May 20 onwards (broadly 50 percent of outlets being open) and June (saw broadly 80 percent of outlets open). The recovery has continued in July," said the company.

RELATED NEWS 

Lupin shares fall 6% after Q1 net profit falls 60% YoY fall

Nomura Investment, Capital Income Builder acquire 1.9% stake in Mindspace REIT

"While near-term demand appears uncertain as a result of the ongoing pandemic and the resultant restrictions across various parts of the country, the company remains focused on restoring volumes and ensuring profitable growth," Motilal Oswal said.

The scrip traded 2.12 percent higher at Rs 1360.15 on BSE around 10:25 hours.




Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com / SD Solutions advises users to check with certified experts before taking any investment decisions.

 

Source – Moneycontrol.com

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more